Evidence map›Paper›PMID 42181495›Full record

ArticleCureus2026

A Presumed Metastatic Lung Lesion Unveiling a Second Primary: Renal Cell Carcinoma With Coinciding Invasive Mucinous Adenocarcinoma.

Kevin T Dao, Sunjum Singh, Parmveer Kaloty, Danial Bandak, Mia Yasonova, Harmanjeet Dhillon, Chandpreet Singh, Wilbur Montana

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kevin T DaoInternal Medicine, UCLA (University of California Los Angeles) Kern Medical, Bakersfield, USA.
Sunjum SinghInternal Medicine, UCLA (University of California Los Angeles) Kern Medical, Bakersfield, USA.
Parmveer KalotyInternal Medicine, UCLA (University of California Los Angeles) Kern Medical, Bakersfield, USA.
Danial BandakInternal Medicine, UCLA (University of California Los Angeles) Kern Medical, Bakersfield, USA.
Mia YasonovaInternal Medicine, UCLA (University of California Los Angeles) Kern Medical, Bakersfield, USA.
Harmanjeet DhillonInternal Medicine, UCLA (University of California Los Angeles) Kern Medical, Bakersfield, USA.
Chandpreet SinghInternal Medicine, UCLA (University of California Los Angeles) Kern Medical, Bakersfield, USA.
Wilbur MontanaHematology and Medical Oncology, UCLA (University of California Los Angeles) Kern Medical, Bakersfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple primary cancer is a self-explanatory term, albeit very uncommon. In most instances, when patients have a malignancy, the possibility of metastasis should be considered. Renal cell carcinoma (RCC) is one such cancer. However, as unlikely as it is, there is always a chance that another separate, unrelated malignancy could be present. Here, we would like to discuss a unique case of a 66-year-old female who not only developed primary RCC but also primary invasive mucinous adenocarcinoma of the lung. This revelation prompted a change in management, resulting in the medical team treating the two malignancies separately via surgical intent as opposed to treating metastatic RCC, which is more geared toward systemic medical therapy.

Indexed as

invasive mucinous adenocarcinoma of the lungmultiple primary malignanciesrenal cell carcinomaseparate malignanciessurgical interventionsystemic medical therapy

Identifiers

PMID42181495
PMCPMC13198223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.